Drugs in upper respiratory tract infections in paediatric patients in North Trinidad

  • Kameel Mungrue
  • Tessa Brown
  • Ivory Hayes
  • Savatri Ramroop
  • Portio Thurston
  • Lexley Pinto Pereira
Keywords: Drug Utilization, Anti-Bacterial Agents, Trinidad and Tobago

Abstract

Objective: We explored the prescribing patterns of physicians in North Trinidad in treating upper respiratory tract infections (URTI) in paediatric patients and the appropriateness of drugs prescribed.

Methods: A retrospective observational study was conducted, with a sample size of 523 paediatric patients, diagnosed with an URTI during the period of June 2003 to 22 June 2005. The study was conducted at five Primary Health Care Facilities in North Trinidad.

Results: The three most frequent URTIs diagnosed were non-specific URTI, common cold, and acute tonsillitis in rank order. Four patterns of prescribing were identified, (1) no drug therapy [1.9%]; (2) antibiotic therapy alone [6.1%]; (3) antibiotic and symptomatic therapy [53.0%]; and (4) symptomatic therapy alone [39.0%]. The, most frequently prescribed antibiotics were penicillins (amoxicillin [46.3%] and amoxicillin/clavulanate [5.3%]) and a macrolide (erythromycin [6.1%]). The three symptomatic agents most frequently prescribed were paracetamol [40.1%]; diphenhydramine [29.1%]; and normal saline nasal drops [14.2%]. In 112 cases with swab analyses done, of these, 98.2% revealed a growth of commensals only, while 1.8% grew pathogenic micro-organisms. Of the cases showing commensal growth only, 84.6% were treated with an antibiotic, 14.5% were treated with symptomatic agents alone and 0.9% received no drug therapy at all.

Conclusions: A large proportion of paediatric patients diagnosed with an URTI in North Trinidad was prescribed antibiotics although not indicated The inappropriate use of antibiotics can potentiate the worldwide trend of antimicrobial resistance.

Downloads

Download data is not yet available.

References

1. Mossad SB. Upper respiratory tract infections. Cleveland Clinic. Department of Infectious Disease. Available at: www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/infectiousdisease/urti/urti1.htm (accessed December 6,2008).

2. Walker R, Edwards C. Clinical Pharmacy and Therapeutics 3rd ed .New York: Churchill Livingstone; 2003.

3. Mohan S, Dharamraj K, Dindial R, Mathur D, Parmasad V, Ramdhanie J, Matthew J, Pinto Pereira LM.Physician behaviour for antimicrobial prescribing for pediatric upper respiratory tract infections: a survey in general practice in Trinidad, West Indies. Ann Clin Microbiol Antimicrob. 2004;3:11.

4. Hueston WJ, Mainous AG, Ornstein S, Pan Q, Jenkins R. Antibiotics for upper respiratory tract infections. Follow up utilization and antibiotic use. Arch Fam Med. 1999;8(5):426-430.

5. Schappert SM. National ambulatory medical care survey, 1991 summary. Hyattsville, Md: National Centre for Health Statistics. Vital health statistics 13, 1994; (116).

6. Benson V, Marano MA. Current estimates from the National Health Interview Survey, 1992.. Vital Health Stat 10. 1994;(189):1-269.

7. Ressel G; Centers for Disease Control and Prevention, American College of Physicians, American Society of Internal Medicine, American Academy of Family Physicians, Infectious Diseases Society of America. Principles of Appropriate Antibiotic Use: Part II. Nonspecific Upper Respiratory Tract Infections. Am Fam Physician. 2001;64(3):510.

8. Mc Caig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA. 1995;273(3):214-219.

9. Fahey T, Stocks N, Thomas T. Systematic review of the treatment of upper respiratory tract infection. Arch Dis Child. 1998;79(3):225-230.

10. The Merck manual of diagnosis and therapy. Section 7 -ear, nose, and throat disorders and chapter 87- pharyngitis. Available at URL: http://www.merck.com (accessed June 6, 2005).

11. Clark M, Kurnar P, Ballinger A, Patchett S. Saunders' pocket essentials of Clinical medicine 3rd ed. London: Elsevier; 2004.

12. Dowel SF, Marcy SM, Phillips WR,Gerber MA, Schwartz B. Principles of Judicious Use of Antimicrobial Agents for Pediatric Upper Respiratory Tract Infections. Pediatrics 1998;101 (1):163-165.

13. Jacobs MR, Dagan R Antimicrobial resistance among pediatric respiratory tract infections: Clinical challenges. Semin Pediatr Infect Dis. 2004;15(1):5-20.

14. Watson RL, Dowell SF, Jayararnan M, Keyserling H, Kolczak M., Schwartz B. Antimicrobial use for pediatric upper respiratory infections: Reported practice, actual practice, and parent beliefs. Pediatrics. 1999;104(6):1251-7.

15. Schwartz B, Marcy SM, Phillips WR, Gerber MA, Dowell SF. Pharyngitis- Principles of judicious use of antimicrobial agents. Pediatrics. 1998;101(1):171-174.

16. Kollef MH, Leeper K. Prevention of infections due to antibiotic-Resistant bacteria.Available at URL: httv://www.medscape.com/viewprogram/4044pnt (accessed June 2, 2005).

17. Hellinger WC. Confronting the problem of increasing antibiotic resistance. South Med J. 2000;93(9):842-8.

18. Stille CJ, Andrade SE, Huang SS, Nordin J, Raebel MA, Go AS, Chan KA, Finkelstein JA. Increased use of second generation macrlide antibiotics for children in nine health plans in the United States. Pediatrics 2004;114(5):1206-1211.

19. Ipp M. Reduced antibiotic use in a paediatric practice: Practical office strategies based on current evidence. Available at URL: http://www.utoronto.ca/kids/aboveruse.htm (accessed on June 6, 2005).

20. Nash DR, Harman J, Wald ER, Kelleher KJ. Antibiotic prescribing by primary care physicians for children with upper respiratory tract infections. Arch Pediatr Adolesc Med. 2002;156(11):1114-1119.

21. Goossens H, Ferech M, Vander Stichele R, Elseviers M; ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365(9459):579-587.

22. Hardman JG, Limbard LE, Molinoff PB, Ruddon RW, Goodman Gilman A. The pharmacological basis of therapeutics. 9th Ed. New York: McGraw Hill; 1996.

23. Dorland’s illustrated medical dictionary, 29th ed. London: Saunders; 2000.

24. Mosby’s medical nursing and allied health dictionary. 6th ed. St.Louis: Mosby; 2002.

25. Minitab Release 14. State College; Pennsylvania: Minitab Inc, 2004.

26. Pukander J, Karma P, Sipila M. Occurrence and recurrence of acute otitis media among children. Acta Otolaryngol. 1982;94(5-6):479-486.

27. Schwartz RH, Freij BJ, Ziai M, Sheridan MJ. Antimicrobial prescribing for acute purulent rhinitis in children: a survey of paediatricians and family practitioners. Pediatr Infect Dis J. 1997;16(2):185-190.

28. Parimi N, Pinto Pereira LM, Prabakar P. The general public’s perception and use of antimicrobials in Trinidad and Tobago. Rev Panam Salud Publica. 2002;12(1):11-18.

29. Britt H, Sayer GP, Miller GC et al. BEACH Bettering the Evaluation and Care of Health. A Study of General Practice Activity. Six-month Interim Report. AIHW cat. No. GEP 1. Canberra: Australian Institute of Health and Welfare (General Practice Series no. 1).

30. Rosenstein N, Phillips WR, Gerber MA, Marcy MS, Schwartz B, Dowell SF. The Common Cold -Principles of Judicious Use of Antimicrobial agents. Pediairics 1998;101(1):181-184.

31. Rammelkamp CH Jr. Rheumatic heart disease -a challenge. Circulation. 1958;17(5):842-851.

32. Putto A .Febrile exudative tonsillitis: viral or streptococcal? Pediatrics. 1987;80(1):6-12.

33. Schwartz B, Marcy M, Phillips WR, Gerber MA, Dowell SF. Otitis Media -Principles of Judicious Use of Antimicrobial Agents. Pediatrics 1998;101(1):165-171.

34. American Academy of Family Physicians (AAFP) and American Academy of Pediatrics (AAP). Diagnosis and Management of Acute Otitis Media Available at URL: http://www.aafp.org/x26481.xml. (accessed April 12, 2006).

35. Piglansky L, Leibovitz E, Raiz S, Greenberg D, Press J, Leiberman A, Dagan R. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children. Pediatr Infect Dis J. 2003;22(5):405-413.

36. Chidiac C, Maulin L. [Using antibiotics in case of influenza]. Med Mal Infect. 2006;36(4):181-189.

37. Townsend EH Jr, Radebaugh JF. Prevention of Complications of Respiratory Illness in Paediatric Practice: A Double-Blinded Study. N Engl J Med. 1962;266:683-689.
Published
2009-03-04
How to Cite
1.
Mungrue K, Brown T, Hayes I, Ramroop S, Thurston P, Pinto Pereira L. Drugs in upper respiratory tract infections in paediatric patients in North Trinidad. Pharm Pract (Granada) [Internet]. 2009Mar.4 [cited 2020Feb.17];7(1):29-3. Available from: https://pharmacypractice.org/journal/index.php/pp/article/view/188
Section
Original Research